Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Integrating Theranostics Into Patient Care Pathways: AJR Expert Panel Narrative Review.

O'Shea, Aileen; Iravani, Amir; Saboury, Babak; Jadvar, Hossein; Catalano, Onofrio; Mahmood, Umar; Heidari, Pedram.

AJR Am J Roentgenol ; 220(5): 619-629, 2023 05.

Artículo en Inglés | MEDLINE | ID: mdl-36321986

2.

Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.

Herrmann, Ken; Giovanella, Luca; Santos, Andrea; Gear, Jonathan; Kiratli, Pinar Ozgen; Kurth, Jens; Denis-Bacelar, Ana M; Hustinx, Roland; Patt, Marianne; Wahl, Richard L; Paez, Diana; Giammarile, Francesco; Jadvar, Hossein; Pandit-Taskar, Neeta; Ghesani, Munir; Kunikowska, Jolanta.

Eur J Nucl Med Mol Imaging ; 49(7): 2300-2309, 2022 06.

Artículo en Inglés | MEDLINE | ID: mdl-35403861

3.

Targeted α-therapy in non-prostate malignancies.

Jadvar, Hossein; Colletti, Patrick M.

Eur J Nucl Med Mol Imaging ; 49(1): 47-53, 2021 12.

Artículo en Inglés | MEDLINE | ID: mdl-33993386

4.

Role of ¹⁸F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review.

Savir-Baruch, Bital; Choyke, Peter L; Rowe, Steven P; Schuster, David M; Subramaniam, Rathan M; Jadvar, Hossein.

AJR Am J Roentgenol ; 216(4): 851-859, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33206564

5.

¹⁸F-fluciclovine PET-CT and ⁶⁸Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

Calais, Jeremie; Ceci, Francesco; Eiber, Matthias; Hope, Thomas A; Hofman, Michael S; Rischpler, Christoph; Bach-Gansmo, Tore; Nanni, Cristina; Savir-Baruch, Bital; Elashoff, David; Grogan, Tristan; Dahlbom, Magnus; Slavik, Roger; Gartmann, Jeannine; Nguyen, Kathleen; Lok, Vincent; Jadvar, Hossein; Kishan, Amar U; Rettig, Matthew B; Reiter, Robert E; Fendler, Wolfgang P; Czernin, Johannes.

Lancet Oncol ; 20(9): 1286-1294, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31375469

6.

Preclinical evaluation of a ⁶⁴Cu-labeled disintegrin for PET imaging of prostate cancer.

Jadvar, Hossein; Chen, Kai; Park, Ryan; Yap, Li-Peng; Vorobyova, Ivetta; Swenson, Steve; Markland, Francis S.

Amino Acids ; 51(10-12): 1569-1575, 2019 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-31621030

7.

Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers.

Osmany, Saabry; Zaheer, Sumbul; Bartel, Twyla B; Johnston, Mickaila; Peh, Wee Ming; Barmaky, Salwa; Jadvar, Hossein.

AJR Am J Roentgenol ; 213(2): 286-299, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-31166760

8.

PSMA Theranostics: Current Status and Future Directions.

Rahbar, Kambiz; Afshar-Oromieh, Ali; Jadvar, Hossein; Ahmadzadehfar, Hojjat.

Mol Imaging ; 17: 1536012118776068, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-29873291

9.

Radiotheranostics in Cancer Diagnosis and Management.

Jadvar, Hossein; Chen, Xiaoyuan; Cai, Weibo; Mahmood, Umar.

Radiology ; 286(2): 388-400, 2018 02.

Artículo en Inglés | MEDLINE | ID: mdl-29356634

10.

Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging.

Gholamrezanezhad, Ali; Basques, Kyle; Batouli, Ali; Matcuk, George; Alavi, Abass; Jadvar, Hossein.

AJR Am J Roentgenol ; 210(6): W245-W263, 2018 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-29787313

11.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Jaffee, Elizabeth M; Dang, Chi Van; Agus, David B; Alexander, Brian M; Anderson, Kenneth C; Ashworth, Alan; Barker, Anna D; Bastani, Roshan; Bhatia, Sangeeta; Bluestone, Jeffrey A; Brawley, Otis; Butte, Atul J; Coit, Daniel G; Davidson, Nancy E; Davis, Mark; DePinho, Ronald A; Diasio, Robert B; Draetta, Giulio; Frazier, A Lindsay; Futreal, Andrew; Gambhir, Sam S; Ganz, Patricia A; Garraway, Levi; Gerson, Stanton; Gupta, Sumit; Heath, James; Hoffman, Ruth I; Hudis, Cliff; Hughes-Halbert, Chanita; Ibrahim, Ramy; Jadvar, Hossein; Kavanagh, Brian; Kittles, Rick; Le, Quynh-Thu; Lippman, Scott M; Mankoff, David; Mardis, Elaine R; Mayer, Deborah K; McMasters, Kelly; Meropol, Neal J; Mitchell, Beverly; Naredi, Peter; Ornish, Dean; Pawlik, Timothy M; Peppercorn, Jeffrey; Pomper, Martin G; Raghavan, Derek; Ritchie, Christine; Schwarz, Sally W; Sullivan, Richard.

Lancet Oncol ; 18(11): e653-e706, 2017 11.

Artículo en Inglés | MEDLINE | ID: mdl-29208398

12.

Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.

Jadvar, Hossein.

Radiology ; 304(3): 609-610, 2022 09.

Artículo en Inglés | MEDLINE | ID: mdl-35608452

13.

Science to Practice: Does FDG Differentiate Morphologically Unstable from Stable Atherosclerotic Plaque?

Dilsizian, Vasken; Jadvar, Hossein.

Radiology ; 283(1): 1-3, 2017 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-28318446

14.

Highlights of articles published in annals of nuclear medicine 2016.

Jadvar, Hossein.

Eur J Nucl Med Mol Imaging ; 44(11): 1928-1933, 2017 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-28752226

15.

SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI.

Ruddy, Terrence D; Al-Mallah, Mouaz; Arrighi, James A; Bois, John P; Bluemke, David A; Di Carli, Marcelo F; Dilsizian, Vasken; Gropler, Robert J; Jadvar, Hossein; Malhotra, Saurabh; Pelletier-Galarneau, Matthieu; Schindler, Thomas H; Woodard, Pamela K; Chareonthaitawee, Panithaya.

J Cardiovasc Magn Reson ; 24(1): 43, 2022 07 19.

Artículo en Inglés | MEDLINE | ID: mdl-35850721

16.

Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.

Jadvar, Hossein.

AJR Am J Roentgenol ; 209(2): 277-288, 2017 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-28463538

17.

Competitive Advantage of PSMA Theranostics in Prostate Cancer.

Jadvar, Hossein.

Radiology ; 299(2): 261-263, 2021 05.

Artículo en Inglés | MEDLINE | ID: mdl-33788590

18.

Invited Commentary: Nuclear Theranostics-The Path Forward.

Greenspan, Bennett S; Jadvar, Hossein.

Radiographics ; 40(6): 1741-1742, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-33016813

19.

Editorial Comment.

Luis de Castro Abreu, Andre; Jadvar, Hossein.

J Urol ; 202(2): 420-421, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-31094671

20.

Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer.

Jadvar, Hossein.

Eur J Nucl Med Mol Imaging ; 46(1): 8-10, 2019 01.

Artículo en Inglés | MEDLINE | ID: mdl-30310953

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Integrating Theranostics Into Patient Care Pathways: AJR Expert Panel Narrative Review.

Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.

Targeted α-therapy in non-prostate malignancies.

Role of ¹⁸F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review.

¹⁸F-fluciclovine PET-CT and ⁶⁸Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

Preclinical evaluation of a ⁶⁴Cu-labeled disintegrin for PET imaging of prostate cancer.

Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers.

PSMA Theranostics: Current Status and Future Directions.

Radiotheranostics in Cancer Diagnosis and Management.

Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.

Science to Practice: Does FDG Differentiate Morphologically Unstable from Stable Atherosclerotic Plaque?

Highlights of articles published in annals of nuclear medicine 2016.

SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI.

Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.

Competitive Advantage of PSMA Theranostics in Prostate Cancer.

Invited Commentary: Nuclear Theranostics-The Path Forward.

Editorial Comment.

Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer.